NMDPD's aim is to discuss the new developments in the understanding of the non-motor aspects of Parkinson's disease and other movement disorders and their management. During this exciting congress, we shall have an opportunity to deliberate on brain diseases and how they contribute to cognition and behavior. We shall discuss the psychological markers of Parkinson's dementia and of dementia with Lewy bodies, and also the biochemical and genetic factors involved. The identification in recent years of widespread alpha-synuclein deposits, from the periphery and up to the cortex, has contributed to our understanding but at the same time raised new and still unanswered questions as well as exciting new therapeutic possibilities. The overlap with Alzheimer's disease and with fronto-temporal dementia will be two other central issues.
Delirium, dementia, anxiety, psychosis and impulse control disorders frequently affect the lives of patients and caregivers even more than motor disturbances, and they therefore deserve special attention. Besides cognitive impairment, patients with movement disorders frequently complain of disturbances of the autonomic nervous system, REM sleep behavior disorder, and hyposmia, to name a few. All these aspects will be discussed in detail.
We encourage you to not only attend the congress but to also submit an abstract, thereby contributing to what we are confident will be a splendid scientific program.
We look forward to welcoming you at the NMDPD Congress!